Eagle Pharmaceuticals prices IPO at $15, the midpoint of the range – NASDAQ
|
Eagle Pharmaceuticals prices IPO at $ 15, the midpoint of the range
NASDAQ Eagle Pharmaceuticals, which develops and sells enhanced injectable versions of expiring patented drugs, raised $ 50 million by offering 3.4 million shares at $ 15, the midpoint of the range of $ 14 to $ 16. Eagle Pharmaceuticals plans to list on the … |
